GayathriNagarajMD
Oncology • Loma Linda, CABreast Cancer, Hematologic Oncology
Associate Professor of Medicine Program Director, Hematology/Oncology Fellowship Loma Linda University School of Medicine
Dr. Nagaraj is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
11234 Anderson St
Schuman Pavilion, Room A600
Loma Linda, CA 92354Phone+1 909-558-2262Fax+1 909-651-5939- Is this information wrong?
Summary
- Dr. Gayathri Nagaraj is an oncologist in Loma Linda, CA and is affiliated with Loma Linda University Medical Center. She received her medical degree from Bangalore Medical College and has been in practice 15 years. She specializes in hematologic oncology.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2009 - 2012
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 2005 - 2008
Bangalore Medical CollegeClass of 2002
Certifications & Licensure
CA State Medical License 2007 - 2025
MO State Medical License 2009 - 2012
PA State Medical License 2005 - 2008- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.Castellano, C., Sun, T., Ravindranathan, D., Hwang, C., Balanchivadze, N., Singh, S., Griffiths, E., Puzanov, I., Ruiz-Garcia, E., Vilar-Compte, D., Cárdenas-Delgado, ...> ;Cancer. 2024 Feb 20
- Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, Jared D Acoba, Joy Awosika, Ziad Bakouny, Nicole B Balmaceda, Ting ...> ;Elife. 2023 Oct 17
- Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.Vikas, P., Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, Pankil K Shah, Rebecca Zon, Susan Alsamarai, Joy Awosika, Ziad El-Bakouny, Babar Bashir, Alicia Beeghly, Stephani...> ;JAMA Oncology. 2023 Oct 1
- Join now to see all
Press Mentions
Woman Overcomes Breast Cancer Again, and Again, and AgainOctober 26th, 2021- Study: Demographic Factors Associated with Poorer Outcomes in Cancer Patients Who Contract COVID-19March 23rd, 2021
Woman Diagnosed with Breast Cancer During Pregnancy Gave Birth to ‘Miracle Baby’March 30th, 2020- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Loma Linda University Medical CenterLoma Linda, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
